4//SEC Filing
Wilson Jason Douglas 4
Accession 0001209191-19-056130
CIK 0001358762other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 5:41 PM ET
Size
8.7 KB
Accession
0001209191-19-056130
Insider Transaction Report
Form 4
Wilson Jason Douglas
See Remarks
Transactions
- Award
Employee Stock Option (right to buy)
2019-11-11+17,250→ 17,250 totalExercise: $55.73Exp: 2029-01-02→ Class B common stock (17,250 underlying) - Award
Employee Stock Option (right to buy)
2019-10-14+17,250→ 17,250 totalExercise: $55.73Exp: 2029-01-02→ Class B common stock (17,250 underlying)
Footnotes (2)
- [F1]On January 2, 2019, the reporting person was granted an option to purchase 69,000 shares of Class B common stock. As previously reported, the option vests as to 34,500 shares in sixteen equal quarterly installments beginning on April 2, 2019, subject to continued service through each vesting date. On October 14, 2019, based on the satisfaction of certain performance criteria, the option vested as to 4,312 shares and the option was set to vest as to 12,938 shares in twelve equal quarterly installments beginning on January 14, 2020, subject to continued service through each vesting date. On November 11, 2019, based on the satisfaction of certain performance criteria, the option vested as to 4,312 shares and the option was set to vest as to 12,938 shares in twelve equal quarterly installments beginning on February 11, 2020, subject to continued service through each vesting date.
- [F2]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001662395
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 5:41 PM ET
- Size
- 8.7 KB